Last reviewed · How we verify
NCT07025356
Observational Study of the the Use of a Trigeminal Vagal Nerve Stimulator in the Routine Care of Native Americans With Diabetic Neuropathy Pain. Pain Scores, Drug Use and Glucose Measurements Will be Assessed
trial testing Implantation of a trigeminal Vagus cervical nerve stimulator system in Diabetic Neuropathy With Neurologic Complication in 83 participants. Completed in 1 June 2025.
23 April 2024
Quick facts
| Lead sponsor | Vagus Nerve Society |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 83 |
| Start date | 23 September 2022 |
| Primary completion | 23 April 2024 |
| Estimated completion | 1 June 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Implantation of a trigeminal Vagus cervical nerve stimulator system — full drug profile →
- Implantation of a neurostimulator system for trigeminal vagal cervical nerve stimulation
Conditions studied
- Diabetic Neuropathy With Neurologic Complication — all drugs for Diabetic Neuropathy With Neurologic Complication →
Sponsor
Vagus Nerve Society
Who can join
Adults 18 to 89, any sex, with Diabetic Neuropathy With Neurologic Complication. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is an observational study that will follow patients in the course of routine care and measure pain levels, glucose assessments and drug utilization for native American patients with diabetic neuropathy
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07025356
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07025356 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Vagus Nerve Society
- Last refreshed: 17 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07025356.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing